Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

As Ophthalmology Times celebrates its 50th anniversary, the moment serves as an opportunity to reflect on the innovations ...

The Glaucoma Research Foundation (GRF) announced it has appointed Cynthia Steel, PhD, MBA, as Chief Scientific Officer (CSO).

PainReform announced it has acquired a majority equity interest in LayerBio, focusing on LayerBio's OcuRing-K technology, for ...

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

AAVB-039 is the company’s gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4.

This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...

The ADAPT study will evaluate the safety and effectiveness of the Calibreye surgical system in up to 70 patients with ...

AI plays a crucial role in the segmentation of diagnostic imaging, another area where precision is paramount. This platform ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...